Meihua International Medical Technologies Co annual r&d spending
2019
2020
2021
2022
2023
2024
2025
Meihua International Medical Technologies Co R&D Spending Growth & History (MHUAF)
Meihua International Medical Technologies Co's r&d spending was $2.4M for fiscal 2025.
View full Meihua International Medical Technologies Co company overviewMeihua International Medical Technologies Co annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.4M | −$1.1M | −31.05% |
| 2024 | 2024-12-31 | $3.5M | $702,783 | +25.52% |
| 2023 | 2023-12-31 | $2.8M | −$209,589 | −7.07% |
| 2022 | 2022-12-31 | $3.0M | $237,890 | +8.73% |
| 2021 | 2021-12-31 | $2.7M | $232,955 | +9.35% |
| 2020 | 2020-12-31 | $2.5M | −$722,267 | −22.47% |
| 2019 | 2019-12-31 | $3.2M | — | — |
Meihua International Medical Technologies Co r&d spending trends
Over the last five fiscal years, Meihua International Medical Technologies Co's r&d spending decreased from $2.5M to $2.4M, a change of −$109,075.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Meihua International Medical Technologies Co source filings ↗